MedTech Dive
VerifiedOnline/Digital
MedTech Dive provides in-depth journalism and insight into the most impactful news and trends shaping medical technology. The newsletters and website cover topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more. Source
Actions
Media Outlet details
| Scope | National, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesOsteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health
REDWOOD CITY, Calif. — More than 2,500 physicians have prescribed Osteoboost to date, the first FDA-cleared prescription wearable empowering women to proactively protect and preserve their bone density and bone strength Osteoboost Health, Inc., today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden the commercial reach of the company’s FDA-cleared medical device for low bone density.
Don't miss tomorrow's medtech industry news
In sterile barrier packaging, failure rarely announces itself clearly. It appears as an intermittent tear instead of a clean peel, a failed pressure test that cannot be consistently replicated or a seal that seems strong but behaves unpredictably under stress. Consider the following real-world example: a device requiring a controlled adhesive peel from a small sealing flange (~1mm) on a cylindrical cavity began failing during release testing.
ACTO Unveils First Ever Role-based AI SuperAgents Purpose-Built to Orchestrate Work for Life Sciences Field Teams
NEW YORK — ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced the launch of SuperAgents, an industry-first AI innovation designed to orchestrate work for Life Sciences customer-facing professionals. Unlike traditional AI tools that focus on isolated tasks and workflows, ACTO SuperAgents are purpose-built around the workforce—empowering individuals in their roles with intelligent, contextual, and compliant support.
Don't miss tomorrow's medtech industry news Original
This audio is auto-generated. Please let us know if you have feedback. Endovascular Engineering has raised $80 million to bring to market its mechanical thrombectomy platform to treat pulmonary embolism. The new financing will help E2 scale up its commercial organization while continuing to invest in R&D and operations, the company said Tuesday.
Don't miss tomorrow's medtech industry news Original
This audio is auto-generated. Please let us know if you have feedback. One year after President Donald Trump’s “Liberation Day” declaration in a White House Rose Garden ceremony unleashed a tariff policy targeting top U.S. trading partners, medtech companies are still absorbing the shocks.
Don't miss tomorrow's medtech industry news
SAN JOSE, Calif. — MEDvidi, an AI-powered mental health company, launches its AI Prescribing Assistant, whichhelps clinicians across the US manage routine medication renewals for patients with ADHD, anxiety, and depression. While the system automates workflow, all prescribing decisions remain under the control of licensed physicians.
Don't miss tomorrow's medtech industry news Original
This audio is auto-generated. Please let us know if you have feedback. Johnson & Johnson said Tuesday it is introducing the Varipulse Pro pulsed field ablation device in Europe, where it has received CE mark approval. The atrial fibrillation treatment has a lower temperature profile compared to the current version of Varipulse and competitive devices, J&J said. Ablation is five times faster than the previous Varipulse sequence, while achieving equivalent lesions, according to the company.
Don't miss tomorrow's medtech industry news
This audio is auto-generated. Please let us know if you have feedback. VDyne said the Food and Drug Administration approved an investigational device exemption for a pivotal clinical trial of its transcatheter tricuspid valve replacement system. The approval, announced last week, moves VDyne a step closer to competing with Edwards Lifesciences’ Evoque tricuspid valve replacement device.
Don't miss tomorrow's medtech industry news
HOUSTON — Prana Surgical, a Houston-based medical device company, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the Prana System™, an electrosurgical device indicated to remove tissue and control bleeding. The Prana System is a sterile, single-use electrosurgical tool designed for use with standard generators, enabling physicians to localize and excise tissue in a controlled, minimally invasive manner.
Don't miss tomorrow's medtech industry news
SAN DIEGO — Exactice Medical, Inc. today announced a definitive agreement with ImSonic Medical, Inc. to complete advanced prototype development of its AIM device—the industry’s first combined imaging and transseptal access solution, designed to make transseptal procedures faster, safer, and more cost-effective. Exactice’s proprietary AIM device combines 2D/3D intracardiac echocardiography (ICE) with a fully integrated, deployable steerable needle guide.